Free Trial
CVE:COV

Covalon Technologies (COV) Stock Price, News & Analysis

Covalon Technologies logo
C$3.83 -0.07 (-1.79%)
(As of 05:21 PM ET)

About Covalon Technologies Stock (CVE:COV)

Key Stats

Today's Range
C$3.83
C$3.94
50-Day Range
C$2.95
C$4.07
52-Week Range
C$0.96
C$4.30
Volume
1,422 shs
Average Volume
19,926 shs
Market Capitalization
C$104.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity. It also offers medical coating platform, a process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device. In addition, the company provides wound care dressings; surgical and peri-operative; and infection management products. It offers its products under the Covalon brand name through third-party distribution networks and company's direct sales force. The company serves hospitals, wound care centers, burn centers, extended/alternate care and acute care facilities, home health care agencies, and physicians' offices. Covalon Technologies Ltd. is headquartered in Mississauga, Canada.

Receive COV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Covalon Technologies and its competitors with MarketBeat's FREE daily newsletter.

COV Stock News Headlines

COV:CA Covalon Technologies Ltd.
Trump won. Buy this coin now.
Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.
CVALF Covalon Technologies Ltd.
See More Headlines

COV Stock Analysis - Frequently Asked Questions

Covalon Technologies' stock was trading at C$1.06 at the beginning of 2024. Since then, COV shares have increased by 261.3% and is now trading at C$3.83.
View the best growth stocks for 2024 here
.

Shares of COV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Covalon Technologies investors own include NIO (NIO), Reliq Health Technologies (RHT), Facedrive (FDVRF), Meta Platforms (META), NVIDIA (NVDA), Ackroo (AKR) and BeWhere (BEW).

Company Calendar

Today
11/21/2024
Next Earnings (Estimated)
1/24/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
C$-2,770,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$29.20 million
Cash Flow
C$0.90 per share
Book Value
C$0.88 per share

Miscellaneous

Free Float
N/A
Market Cap
C$104.94 million
Optionable
Not Optionable
Beta
0.64
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

This page (CVE:COV) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners